NCT04600505 - A Study to Assess Drug Absorption of Fixed Dose Combinations of Budesonide, Glycopyrronium, and Formoterol | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 19, 2020

Primary Completion Date

May 17, 2021

Study Completion Date

May 17, 2021

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG

Treatment A

Participants will receive 2 inhalations of BGF MDI with propellant 1.

DRUG

Treatment B

Participants will receive 2 inhalations of BGF MDI with propellant 2.

DRUG

Treatment C

Participants will receive 2 inhalations of BGF MDI with HFA propellant.

Trial Locations (1)

Research Site, Glendale